High-Dose Megestrol in Treating Patients With Metastatic Breast Cancer, Endometrial Cancer, or Mesothelioma - Related Studies

High-Dose Megestrol in Treating Patients With Metastatic Breast Cancer, Endometrial Cancer, or Mesothelioma

This study is ongoing, but not recruiting participants.

Study NCT00002465. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Breast Cancer
		Endometrial Cancer
		Malignant Mesothelioma

2	Additional conditions recognized in this trial
		Breast Neoplasms
		Endometrial Neoplasms
		Mesothelioma

3	More general conditions related to this trial
		Adenoma
		Breast Diseases
		Genital Diseases, Female
		Genital Neoplasms, Female
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms by Site
		Neoplasms, Glandular and Epithelial
		Neoplasms, Mesothelial
		Skin Diseases
		Urogenital Neoplasms
		Uterine Diseases
		Uterine Neoplasms

4	Interventions listed in this trial
		megestrol acetate

5	Additional drug interventions recognized in this trial
		Megestrol

6	More general drug interventions related to this trial
		Antineoplastic Agents
		Antineoplastic Agents, Hormonal
		Appetite Stimulants
		Central Nervous System Agents
		Central Nervous System Stimulants
		Contraceptive Agents
		Contraceptive Agents, Female
		Contraceptives, Oral
		Contraceptives, Oral, Synthetic
		Pharmacologic Actions
		Physiological Effects of Drugs
		Reproductive Control Agents
		Therapeutic Uses

7	Sponsors listed in this trial
		St. Vincent Medical Center - Los Angeles